Taiwan to step up checks on US beef after mad cow case

Taiwan plans to step up checks of US plants that process beef exported to the island, the government said Sunday, following the discovery of a new mad cow disease case in the United States.

The US Department of Agriculture (USDA) last week reported the country's fourth-ever case of (BSE), but stressed the was contained and no contaminated meat had entered the food chain.

USDA Secretary Tom Vilsack wrote a letter to his Taiwanese counterpart on Friday outlining the measures being adopted by the US authorities and pledged to keep Taiwan informed about the investigation of the case.

Taiwan said Sunday that officials planned to visit the US soon due to "concerns" following the new case.

"In order to clarify concerns and ensure safety of , officials from the Council of Agriculture and the Department of Health will visit the United States as soon as possible," the council said in a statement.

Taiwan, like many other governments, banned US beef imports in December 2003 after was detected in an American herd but relaxed the rules in 2006 to allow imports of boneless beef.

Taiwan moved in October 2009 to allow US beef on the bone, cow organs and minced beef, but the decision was overturned after a public outcry.

Related Stories

US animal feed, beef safe from mad cow: FDA

date Apr 26, 2012

US food safety authorities on Thursday called a new case of mad cow disease in California "atypical" and said they were confident in measures to prevent the disease from spreading via animal feed.

US moves to contain mad cow fallout

date Apr 25, 2012

The United States scrambled on Wednesday to contain the fallout from the discovery of mad cow disease in California as the top beef exporter insisted the outbreak posed no threat to consumers.

U.S. confirms another mad cow case

date Mar 14, 2006

The U.S. Department of Agriculture has confirmed the nation's third case of bovine spongiform encephalopathy -- mad cow disease.

Recommended for you

Selecting the right tool for the job

date Apr 14, 2015

Randomized clinical trials of new drugs have long been considered the "gold standard" in determining safety and efficacy before drugs, biologics, vaccines or devices are introduced to the general public. However, in the case ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.